Theratechnologies (THTX) to Release Quarterly Earnings on Wednesday

Theratechnologies (NASDAQ:THTX) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, February 19th. Analysts expect the company to announce earnings of $0.05 per share and revenue of $31.86 million for the quarter.

Theratechnologies Stock Down 1.2 %

Shares of THTX opened at $1.62 on Wednesday. The firm’s fifty day moving average is $1.68 and its two-hundred day moving average is $1.42. The stock has a market cap of $74.49 million, a PE ratio of -16.20 and a beta of 1.26. Theratechnologies has a 52-week low of $1.08 and a 52-week high of $2.18.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.